These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 3185086

  • 1. [Spontaneous seroconversion of HBeAg into anti-HBe in patients with chronic hepatitis B].
    Hadzić N, Vucelić B, Dubravcić D, Juricić M, Stavljenić A.
    Lijec Vjesn; 1988; 110(6-7):181-4. PubMed ID: 3185086
    [No Abstract] [Full Text] [Related]

  • 2. [Seroconversion of HBeAg into anti-HBe in chronic hepatitis type B].
    Stránský J, Vodák M, Zichová M, Votruba T, Choluj B.
    Cas Lek Cesk; 1986 Oct 31; 125(44):1353-6. PubMed ID: 3508397
    [No Abstract] [Full Text] [Related]

  • 3. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
    Stránský J, Chlumská A, Zichová M, Helm R, Mankovecký L, König J.
    Sb Lek; 1993 Oct 31; 94(4):317-25. PubMed ID: 7992018
    [Abstract] [Full Text] [Related]

  • 4. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
    Chlumská A, Stránský J, Taimr P, Baumruk L, Nevaril M.
    Vnitr Lek; 1995 Jul 31; 41(7):445-8. PubMed ID: 7571477
    [Abstract] [Full Text] [Related]

  • 5. [Prognostic significance of the HBeAg-anti-HBe system in acute hepatitis B].
    Ketiladze ES, Vorozhbieva TE, Matveev VA, Bugaeva NP.
    Ter Arkh; 1986 Jul 31; 58(10):23-6. PubMed ID: 3798343
    [No Abstract] [Full Text] [Related]

  • 6. [HBeAg/anti-HBe system in acute viral hepatitis B].
    Gvojić B, Miling M.
    Lijec Vjesn; 1985 May 31; 107(5):191-5. PubMed ID: 4010449
    [No Abstract] [Full Text] [Related]

  • 7. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS, Sung JL, Lai MY.
    Hepatogastroenterology; 1981 Dec 31; 28(6):288-91. PubMed ID: 6284625
    [Abstract] [Full Text] [Related]

  • 8. Clinical and pathophysiological aspects of chronic active hepatitis.
    Iwamura K.
    Tokai J Exp Clin Med; 1986 Dec 31; 11 Suppl():147-57. PubMed ID: 3452239
    [Abstract] [Full Text] [Related]

  • 9. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
    Loriot MA, Marcellin P, Talbodec N, Guigonis V, Gigou M, Boyer N, Bezeaud A, Erlinger S, Benhamou JP.
    Hepatology; 1995 Mar 31; 21(3):627-31. PubMed ID: 7875659
    [Abstract] [Full Text] [Related]

  • 10. HBeAg/anti-HBe antigenic system in liver diseases in Greece.
    Theodoropoulos G, Nakopoulou L, Fertakis A, Papaevangelou G, Hadzis G, Kasfiki A.
    Hepatogastroenterology; 1983 Dec 31; 30(6):243-5. PubMed ID: 6327477
    [Abstract] [Full Text] [Related]

  • 11. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H, Kurimura O, Tamura I, Shimase K, Kaneto E, Kurimura T, Tsuda F, Mayumi M.
    Biken J; 1984 Dec 31; 27(4):169-76. PubMed ID: 6100353
    [Abstract] [Full Text] [Related]

  • 12. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F, D'Arminio Monforte A, Rossi E, Cultraro D, Marescotti C, Moroni M.
    Boll Ist Sieroter Milan; 1981 Dec 31; 60(6):468-79. PubMed ID: 7344717
    [No Abstract] [Full Text] [Related]

  • 13. [A clinicopathological study of seroconversion from HBeAg to anti-HBe in patients with chronic hepatitis B].
    Liu JH, Yan JC, Wang HP.
    Zhonghua Nei Ke Za Zhi; 1988 Oct 31; 27(10):621-3, 653. PubMed ID: 3229186
    [No Abstract] [Full Text] [Related]

  • 14. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
    Musca A, Cordova C, Barnaba V, Bonavita MS, Zaccari C, Levrero M.
    Minerva Dietol Gastroenterol; 1983 Oct 31; 29(1):19-26. PubMed ID: 6843853
    [No Abstract] [Full Text] [Related]

  • 15. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T, Kiyosawa K, Akahane Y, Tanaka E, Wada S, Oike Y, Nakamura M, Yoda H, Imai Y, Gibo Y.
    Am J Gastroenterol; 1986 Apr 31; 81(4):239-45. PubMed ID: 3962948
    [Abstract] [Full Text] [Related]

  • 16. Precore wild-type DNA and immune complexes persist in chronic hepatitis B after seroconversion: no association between genome conversion and seroconversion.
    Maruyama T, Kuwata S, Koike K, Iino S, Yasuda K, Yotsuyanagi H, Moriya K, Maekawa H, Yamada H, Shibata Y, Milich DR.
    Hepatology; 1998 Jan 31; 27(1):245-53. PubMed ID: 9425944
    [Abstract] [Full Text] [Related]

  • 17. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
    Niermeijer P, Gips CH, Huizenga JR, van der Waart M, Schuurs A.
    Hepatogastroenterology; 1980 Oct 31; 27(5):350-5. PubMed ID: 7203369
    [Abstract] [Full Text] [Related]

  • 18. [HBeAg and anti-HBe antibodies in chronic liver diseases].
    Bereszyńska I, Juszczyk J, Kryska A, Kaczmarek Z, Krajewski P.
    Pol Tyg Lek; 1987 Apr 06; 42(14):409-12. PubMed ID: 3615268
    [No Abstract] [Full Text] [Related]

  • 19. The HBe antigen-antibody system and its relationship to epidemiological, histological and biochemical findings in patients with HBV+ HDV chronic liver diseases.
    Jelić D, Jelić O.
    Acta Med Croatica; 1994 Apr 06; 48(2):77-83. PubMed ID: 7519502
    [Abstract] [Full Text] [Related]

  • 20. [Co-existence of HBeAg and anti-HBe in a subject with prolonged hepatitis B].
    Cirelli A, Catania S.
    Clin Ter; 1981 Jul 31; 98(2):215-7. PubMed ID: 7261568
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.